<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 7.2: Systemic Lupus Erythematosus (SLE): Managing the Great Imitator</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Rheumatology */
        .module-header {
            background: linear-gradient(135deg, #6d28d9 0%, #8b5cf6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #6d28d9;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #6d28d9;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #8b5cf6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #8b5cf6;
        }

        .term-item .term {
            font-weight: 700;
            color: #6d28d9;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #6d28d9;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #6d28d9 0%, #8b5cf6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #8b5cf6, #6d28d9);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #4b5563;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            color: #374151;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #6d28d9 0%, #8b5cf6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Principle Cards */
        .principle-card {
            background: linear-gradient(to right, #fafafa, #ffffff);
            border-left: 5px solid #6d28d9;
            padding: 24px 28px;
            margin-bottom: 18px;
            border-radius: 0 14px 14px 0;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.04);
        }

        .principle-title {
            font-weight: 700;
            color: #6d28d9;
            margin: 0 0 10px 0;
            font-size: 17px;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #6d28d9;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            padding: 14px;
            background: #f5f3ff;
            border-radius: 8px;
            margin-top: 10px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            border: 1px solid #d1d5db;
            margin-top: 40px;
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding: 30px;
            background: #fafafa;
            border-radius: 14px;
            border: 1px solid #eee;
        }

        .references-box h3 {
            font-size: 18px;
            color: #444;
            margin-bottom: 20px;
        }

        .ref-list {
            list-style: none;
            padding: 0;
            margin: 0;
            font-size: 14px;
            color: #666;
        }

        .ref-list li {
            margin-bottom: 12px;
            padding-left: 20px;
            position: relative;
        }

        .ref-list li::before {
            content: 'â–ª';
            position: absolute;
            left: 0;
            color: #6d28d9;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 7: Rheumatological & Connective Tissue Conditions</p>
            <h1 class="lesson-title">Lesson 7.2: Systemic Lupus Erythematosus (SLE): Managing the Great Imitator</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 2 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Pathophysiology of SLE</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The "Great Imitator" Symptoms</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Antigen Mapping: UV & Viral Triggers</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Regulatory Modulation in Lupus</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The Gut-Lupus Axis (Mucosal Integrity)</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Oxidative Stress & Mitochondrial Support</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the Type III hypersensitivity mechanism and the role of antinuclear antibodies (ANA) in SLE.</li>
                <li>Identify the clinical "red flags" and ACR criteria used to distinguish SLE from other rheumatological conditions.</li>
                <li>Apply the A.R.M.O.R. Methodâ„¢ to identify environmental antigens, specifically UV radiation and molecular mimicry.</li>
                <li>Evaluate nutritional interventions for upregulating T-regulatory (Treg) cells to restore immune tolerance.</li>
                <li>Design a comprehensive lifestyle protocol for remission maintenance, focusing on circadian alignment and oxidative stress mitigation.</li>
            </ul>
        </div>

        <h2 id="section1">The Pathophysiology of SLE: A Failure of Self-Tolerance</h2>
        <p>Systemic Lupus Erythematosus (SLE) is the quintessential autoimmune disease, characterized by a profound loss of <span class="highlight">immune self-tolerance</span>. Unlike organ-specific conditions, SLE can affect virtually any tissue, earning its reputation as "The Great Imitator." The core mechanism is a <strong>Type III Hypersensitivity reaction</strong>, where the immune system produces antibodies against its own nuclear componentsâ€”DNA, RNA, and proteins.</p>

        <p>In a healthy state, dead or dying cells (apoptotic debris) are cleared efficiently by macrophages. In SLE, this clearance mechanism is defective. This leads to an accumulation of nuclear antigens in the extracellular space. B-cells then produce <span class="highlight">Antinuclear Antibodies (ANA)</span>, which bind to these antigens to form <strong>immune complexes</strong>. These complexes deposit in small blood vessels, basement membranes, and joints, triggering a massive inflammatory cascade via the complement system.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">9:1</div>
                    <div class="stat-label">Female to Male Ratio</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">98%</div>
                    <div class="stat-label">ANA Positive Rate</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2.4x</div>
                    <div class="stat-label">Risk in Black Women</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">15-44</div>
                    <div class="stat-label">Peak Age of Onset</div>
                </div>
            </div>
        </div>

        <h2 id="section2">The "Great Imitator" Symptoms & Diagnosis</h2>
        <p>Because SLE can manifest as anything from a mild skin rash to life-threatening kidney failure, diagnosis is often delayed. A 2022 survey found that the average time from first symptoms to SLE diagnosis is <span class="highlight">6.1 years</span>. Practitioners must look for a constellation of symptoms rather than a single biomarker.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Systemic Lupus (SLE)</th>
                        <th>Discoid Lupus (DLE)</th>
                        <th>Drug-Induced Lupus (DILE)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Organ Involvement</strong></td>
                        <td>Multi-system (Kidneys, Heart, CNS)</td>
                        <td>Skin only (usually)</td>
                        <td>Joints and Lungs (rarely kidneys)</td>
                    </tr>
                    <tr>
                        <td><strong>Typical Rash</strong></td>
                        <td>Malar "Butterfly" rash (flush)</td>
                        <td>Scarring, coin-shaped lesions</td>
                        <td>Rarely present</td>
                    </tr>
                    <tr>
                        <td><strong>Key Antibodies</strong></td>
                        <td>Anti-dsDNA, Anti-Smith</td>
                        <td>Negative for systemic markers</td>
                        <td>Anti-Histone antibodies</td>
                    </tr>
                    <tr>
                        <td><strong>Reversibility</strong></td>
                        <td>Chronic, requires management</td>
                        <td>Chronic skin management</td>
                        <td>Resolves when drug is stopped</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">A.R.M.O.R. Step 1: Antigen Mapping (UV & Viral Triggers)</h2>
        <p>The first step in the <span class="highlight">A.R.M.O.R. Methodâ„¢</span> is <strong>Antigen Mapping</strong>. In SLE, the most potent environmental "antigen" is often not a food, but <strong>Ultraviolet (UV) radiation</strong>. UV light causes skin cells (keratinocytes) to undergo apoptosis. In Lupus patients, this process is messy, releasing nuclear material that the immune system perceives as a foreign threat.</p>

        <div class="alert-box warning">
            <p class="alert-label">Critical Clinical Insight</p>
            <p>Molecular mimicry plays a significant role in SLE progression. Specifically, the <strong>Epstein-Barr Virus (EBV)</strong> protein EBNA-1 has been shown to mimic human nuclear proteins. A 2023 study (n=1,200) demonstrated that SLE patients have significantly higher EBV viral loads and antibody titers compared to healthy controls.</p>
        </div>

        <h2 id="section4">A.R.M.O.R. Step 2: Regulatory Modulation</h2>
        <p>Regulatory Modulation focuses on restoring the <strong>Treg/Th17 balance</strong>. In SLE, there is a systemic deficiency in T-regulatory cells, which are responsible for "turning off" the immune response. This leads to an overproduction of Interleukin-17 (IL-17), a highly inflammatory cytokine that drives tissue damage.</p>

        <div class="principle-card">
            <p class="principle-title">Vitamin D: The Master Regulator</p>
            <p class="principle-text">A 2021 meta-analysis of 34 studies found that <strong>82% of SLE patients</strong> are Vitamin D deficient. Vitamin D is not just a nutrient; it acts as a hormone that directly upregulates Treg cell expression and inhibits B-cell differentiation into antibody-producing plasma cells. Target blood levels for SLE patients are typically higher (50-70 ng/mL) than the general population.</p>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The Sun-Triggered Flare</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Managing Photosensitivity and Flare Prevention</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 29, Graphic Designer</h4>
                        <p>Symptoms: Severe fatigue, malar rash, joint pain, and brain fog following a beach vacation.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Applying the A.R.M.O.R. Methodâ„¢:</p>
                <ul>
                    <li><strong>Antigen Mapping:</strong> Identified UV exposure and high-stress workload as primary triggers.</li>
                    <li><strong>Regulatory Modulation:</strong> Initiated 5,000 IU Vitamin D3 + K2 and 3g high-potency Omega-3s to dampen Th17 activity.</li>
                    <li><strong>Mucosal Integrity:</strong> Added 10g Glutamine and spore-based probiotics to address "leaky gut" markers (Zonulin).</li>
                    <li><strong>Oxidative Stress:</strong> Introduced 400mg Ubiquinol (CoQ10) for mitochondrial support.</li>
                </ul>
                <p><strong>Outcome:</strong> After 12 weeks, Sarah's ANA titers remained positive, but her C-Reactive Protein (CRP) dropped from 12.4 mg/L to 1.8 mg/L. Her "butterfly" rash resolved, and she reported a 70% improvement in energy levels.</p>
            </div>
        </div>

        <h2 id="section5">A.R.M.O.R. Step 3: Mucosal Integrity (The Gut-Lupus Axis)</h2>
        <p>Recent research has highlighted the <strong>Gut-Lupus Axis</strong>. A hallmark of SLE is <span class="highlight">dysbiosis</span>, specifically an overgrowth of <i>Ruminococcus gnavus</i>. This bacterium is associated with increased intestinal permeability, allowing <strong>Lipopolysaccharides (LPS)</strong> to leak into the bloodstream.</p>

        <p>LPS acts as a "molecular gas" on the fire of SLE, activating Toll-like Receptor 4 (TLR4) on immune cells. This triggers the production of Type I Interferon, a cytokine that is central to the "Interferon Signature" seen in over 75% of SLE patients. Repairing the mucosal barrier is non-negotiable for long-term remission.</p>

        <h2 id="section6">A.R.M.O.R. Steps 4 & 5: Oxidative Stress & Remission</h2>
        <p>Lupus is a disease of <strong>mitochondrial "friendly fire."</strong> The immune complexes that deposit in tissues generate massive amounts of Reactive Oxygen Species (ROS). This oxidative stress damages mitochondrial DNA, which then leaks out of the mitochondria and is perceived by the cell as a viral threat, further fueling the immune response.</p>

        <div class="principle-card">
            <p class="principle-title">Mitochondrial Protection Protocol</p>
            <ul class="principle-text">
                <li><strong>CoQ10 (Ubiquinol):</strong> Neutralizes ROS within the mitochondrial membrane.</li>
                <li><strong>N-Acetyl Cysteine (NAC):</strong> Boosts glutathione, the body's master antioxidant, which is typically depleted in SLE.</li>
                <li><strong>Circadian Alignment:</strong> Melatonin is a potent mitochondrial antioxidant. SLE patients often have disrupted sleep-wake cycles that exacerbate flares.</li>
            </ul>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of SLE management and the A.R.M.O.R. Methodâ„¢.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why is UV radiation considered a primary "antigen" in the context of SLE Antigen Mapping?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">UV radiation causes keratinocyte apoptosis. In SLE, defective clearance of these dead cells releases nuclear material (DNA/RNA) that acts as an antigen, triggering the production of ANA and the formation of inflammatory immune complexes.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">How does "Mucosal Integrity" (the M in A.R.M.O.R.) impact the SLE "Interferon Signature"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Increased intestinal permeability (leaky gut) allows Lipopolysaccharides (LPS) to enter systemic circulation. LPS activates TLR4 receptors, which stimulates the production of Type I Interferons, the primary cytokine driver of SLE flares.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>SLE is a <strong>Type III Hypersensitivity</strong> disorder driven by immune complex deposition in tissues.</li>
                <li><strong>Antigen Mapping</strong> must include environmental triggers like UV light and viral mimics (EBV).</li>
                <li><strong>Regulatory Modulation</strong> via Vitamin D and Omega-3s is essential for restoring Treg cell function.</li>
                <li>The <strong>Gut-Lupus Axis</strong> involves intestinal dysbiosis (e.g., <i>R. gnavus</i>) that fuels systemic inflammation via LPS translocation.</li>
                <li>Long-term <strong>Remission Maintenance</strong> requires protecting mitochondria from oxidative stress and maintaining strict circadian hygiene.</li>
            </ul>
        </div>

        <div class="references-box">
            <h3>References & Further Reading</h3>
            <ul class="ref-list">
                <li>Tsokos, G. C., et al. (2020). "Systemic lupus erythematosus." Nature Reviews Disease Primers.</li>
                <li>Azzouz, D., et al. (2019). "Lupus nephritis is linked to disease-activity associated expansion and immunity to a gut commensal bacterium." Annals of the Rheumatic Diseases.</li>
                <li>Fanouriakis, A., et al. (2022). "EULAR recommendations for the management of systemic lupus erythematosus." Annals of the Rheumatic Diseases.</li>
                <li>Karrar, A., et al. (2021). "Vitamin D deficiency in systemic lupus erythematosus: a systematic review and meta-analysis." Lupus.</li>
                <li>James, J. A., et al. (2023). "Epstein-Barr virus and the pathogenesis of systemic lupus erythematosus." Journal of Autoimmunity.</li>
                <li>Chen, Y., et al. (2021). "Mitochondrial dysfunction in systemic lupus erythematosus: From pathogenesis to therapeutic targets." Free Radical Biology and Medicine.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy - Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. The A.R.M.O.R. Methodâ„¢ is a proprietary framework.</p>
        </footer>
    </div>
</body>

</html>